Exploring key lessons from Charlie Munger's "Poor Charlie's Almanack," focusing on decision-making, character, and lifelong learning.

NeuroSense Therapeutics gains FDA approval for PrimeC, a promising ALS treatment, paving the way for clinical trials and commercial release.